Events calendar

Genchrome is hosting an exclusive online webinar: "Is 2025 a Good Year for Your Deal? Strategic Insights from Pharma Leaders and Investors."

This session is designed for biotech and pharma professionals looking to understand the 2025 landscape for deals and partnerships. Gain exclusive insights from these top industry voices on trends, timing, and strategies that could impact your next deal.

Managing Partner and Head of Investments, Roel Bulthuis will be taking part in the panel to share his insights.

Syncona representative(s)

• Roel Bulthuis, Managing Partner and Head of Investments

Investival Showcase is part of Europe's biggest dedicated healthcare investment week, connecting life science & healthcare executives with capital & partners.

At the event, Associate Partner, Pierre Joffrin will be chairing a panel titled 'Pharma Partnering 2025: Navigating the New Biotech Frontier'.

Syncona representative(s)

• Gonzalo Garcia, Investment Partner
• Nathaniel Dahan, Associate Partner
• Pierre Joffrin, Associate Partner

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

An international annual healthcare conference calendar, attended by key industry leaders and decision makers, bringing together executives from big pharma and biotech, sell side analysts, investors and key media.

At the event, Managing Partner and Head of Investments, Roel Bulthuis will be taking part in a panel to share insights as part of an interactive healthcare scenario.

Syncona representative(s)

• Roel Bulthuis, Managing Partner and Head of Investments

BIO-Europe is Europe's largest partnering event with 5,000+ biopharma professionals from 60+ countries expected to attend. The event provides an exceptional opportunity to connect with potential partners across the sector.

Syncona Investment Partners, Alex Hamilton and Gonzalo Garcia, Associate Partner, Pierre Joffrin, and Analyst, Alessio D'addabbo, will be attending BIO-Europe from 4-6 November. 

Syncona representative(s)

• Alex Hamilton, Investment Partner
• Gonzalo Garcia, Investment Partner
• Pierre Joffrin, Associate Partner
• Alessio D'addabbo, Analyst

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

Now in its third year, the Investment Company Showcase is your chance to hear from more than 30 managers of investment trusts. Sessions will cover investment opportunities from UK equities to emerging markets, high income to cutting-edge tech.

Taking place in a new central London venue, three separate conference rooms offer the flexibility to pick and choose the sessions of most interest and relevance to your investment needs.

During the day, CEO, Chris Hollowood, will be presenting from 10:15 – 10:45 in the Venture Suite.

Syncona representative(s)

• Chris Hollowood, CEO

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com

Sidley brings together senior pharma, biotech, healthcare, private equity, and venture capital executives to share their perspectives on critical issues, trends, and opportunities.

Join Sidley and industry leaders from Syncona and other leading institutions across the globe, including AstraZeneca, BioCentury, Compass Pathways, Flagship Pioneering, IQVIA, LetterOne Health, Microsoft, Mestag Therapeutics, Morgan Stanley, Novartis, Permira, Perspectum, Rothschild & Co., Sofinnova Partners, SV Health Investors and Teva for this all-day event.

During the day, Managing Partner & Head of Investments, Roel Bulthuis will be talking on a panel.

Syncona representative(s)

• Roel Bulthuis, Managing Partner & Head of Investments

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com

BioCentury Grand Rounds will provide an interdisciplinary forum of top academic, investor, biotech and pharma R&D leaders that will showcase groundbreaking research, clinical insights and transformative technologies with significant commercial potential.

During the day, CEO, Chris Hollowood, will be talking on a panel.

Syncona representative(s)

• Chris Hollowood, CEO

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com

A focal point of the life sciences social event calendar, the UK BioIndustry Association's summer party returns to the Langham Hotel. 

Syncona are sponsoring the event with Raghd Rostom (Associate Partner), Michael Kyriakides (Investment Partner) and Gonzalo Garcia (Investment Partner) all in attendance.

Syncona representative(s)

• Raghd Rostom, Associate Partner
• Michael Kyriakides, Investment Partner
• Gonzalo Garcia, Investment Partner

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

12 May — 15 May, London

For more than 20 years, BioEquity Europe has been where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry.

Syncona are sponsoring the 2024 event with Elisa Petris (Lead Partner) and Roel Bulthuis (Managing Partner & Head of Investments) both in attendance.

Syncona representative(s)

• Elisa Petris, Lead Partner
• Roel Bulthuis, Managing Partner & Head of Investments

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

During the 10^th LSX World Congress — the leading partnering, strategy and investment event in Europe, with qualified 1:1 partnering at its core — Gonzalo Garcia, Investment Partner will be taking part on a panel.

Syncona representative(s)

• Gonzalo Garcia, Investment Partners

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

At BioTrinity, OBN's flagship two-day conference for the life sciences industry, Investment Partner, Gonzalo Garcia will be talking on a panel titled 'What does a good deal look like, and what investores (really) want'.

The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and broad range of valued service providers.

Syncona representative(s)

• Gonzalo Garcia, Investment Partner

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

At the London Stock Exchange's 2024 Investment Funds Conference, our CEO, Chris Hollowood will be taking part on a panel titled 'The new landscape for alternative assets'.

Syncona representative(s)

• Chris Hollowood, CEO

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

With over 370 delegates from leading and upcoming drug discovery and technology companies from the UK, Nordic and many other European regions, plus investment firms throughout Europe, this year's Anglonordic Life Science Conference is a key event in the life sciences calendar. 

During the day, our Managing Partner & Head of Investments, Roel Bulthuis will be taking part on a panel titled 'Trends in life sciences investments'.

Syncona representative(s)

• Roel Bulthuis, Managing Partner & Head of Investments

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

The Advanced Therapies Congress features speakers from across the entire value chain of cell and gene therapy development with 10 tracks of content over 2 days.

During the day, Investment Partners, Michael Kyriakides and Gonzalo Garcia will be speaking on panels.

Syncona representative(s)

• Michael Kyriakides, Investment Partner
• Gonzalo Garcia, Investment Partner

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.

BIO-Europe Spring 2024 is taking place in Barcelona, Spain, convening 3,400+ total attendees representing over 2,000 companies and 59 countries.

During the day, Managing Partner & Head of Investments, Roel Bulthuis will be talking on a panel.

Syncona representative(s)

• Roel Bulthuis, Managing Partner & Head of Investments

If you’re interested in meeting any of the Syncona team on the day, please reach out to us on investorrelations@synconaltd.com.